$1.69
-0.02[-1.17%]
At close: Apr 17
$1.69
0[0.00%]
PreMarket: 7:55PM EDT
Rafael Holdings
(NYSE:RFL)Latest News for Rafael Holdings Stock (NYSE:RFL)
Rafael Holdings Stock (NYSE: RFL)
Categories: All
Thursday, December 14, 2023
Monday, October 30, 2023
Tuesday, June 13, 2023
Monday, June 05, 2023
Tuesday, April 04, 2023
Tuesday, March 14, 2023
Friday, February 17, 2023
Thursday, January 05, 2023
Tuesday, December 13, 2022
Monday, October 31, 2022
Wednesday, August 03, 2022
Tuesday, July 12, 2022
Monday, July 11, 2022
Friday, July 08, 2022
Friday, July 01, 2022
Tuesday, June 14, 2022
Wednesday, May 11, 2022
Monday, April 18, 2022
Thursday, March 17, 2022
Monday, March 14, 2022
Monday, March 07, 2022
Thursday, February 17, 2022
Friday, January 21, 2022
Wednesday, December 08, 2021
Tuesday, December 07, 2021
Monday, November 22, 2021
- Rafael Holdings shares are trading lower after the company's CEO and Chief Commercial Officer resigned.Luke J Jacobi - Nov 22, 2021, 7:28AM
- Rafael Holdings Announces Ameet Mallik Will Resign From CEO And Remain As A Director; Co. Elects Howard Jonas As Chairman Of The BoardBenzinga Newsdesk - Nov 22, 2021, 7:27AM
- Rafael Holdings Chair of Board to Take Over CEO ResponsibilitiesLuke J Jacobi - Nov 22, 2021, 7:07AM
Thursday, November 11, 2021
Thursday, November 04, 2021
Wednesday, November 03, 2021
- 54 Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Nov 3, 2021, 12:03PM
- Rafael shares are trading higher after the company announced the European Medicines Agency granted Orphan Drug Designation to the company's CPI-613 for the treatment of patients with relapsed or refractory Burkitt's lymphoma.Benzinga Newsdesk - Nov 3, 2021, 10:10AM
- Rafael Holdings Says European Medicines Agency Grants Orphan Drug Designation To Co's CPI-613 For Treatment Of Patients With Relapsed Or Refractory Burkitt's LymphomaBenzinga Newsdesk - Nov 3, 2021, 9:11AM
Monday, November 01, 2021
Friday, October 29, 2021
Thursday, October 28, 2021
- Rafael Holdings shares are trading lower after the company's Phase 3 trial in metastatic pancreatic cancer did not meet its primary endpoint.Bill Haddad - Oct 28, 2021, 2:48PM
- Mid-Afternoon Market Update: Dow Surges 160 Points; Wolfspeed Shares Gain After Q1 ResultsLisa Levin - Oct 28, 2021, 2:45PM
- Rafael Holdings Shares Resume Trading, Move HigherBenzinga Newsdesk - Oct 28, 2021, 2:13PM
- Rafael Holdings Shares Halted On Circuit BreakerBenzinga Newsdesk - Oct 28, 2021, 2:08PM
- Rafael Holdings Shares Resume TradingBenzinga Newsdesk - Oct 28, 2021, 2:00PM